BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16258161)

  • 1. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
    Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
    Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Mao X; Hamoudi RA; Talbot IC; Baudis M
    Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
    Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.
    Lips EH; Dierssen JW; van Eijk R; Oosting J; Eilers PH; Tollenaar RA; de Graaf EJ; van't Slot R; Wijmenga C; Morreau H; van Wezel T
    Cancer Res; 2005 Nov; 65(22):10188-91. PubMed ID: 16288005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.
    Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikós T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P
    Nat Genet; 2002 Jul; 31(3):295-300. PubMed ID: 12089527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.
    Lindblad-Toh K; Tanenbaum DM; Daly MJ; Winchester E; Lui WO; Villapakkam A; Stanton SE; Larsson C; Hudson TJ; Johnson BE; Lander ES; Meyerson M
    Nat Biotechnol; 2000 Sep; 18(9):1001-5. PubMed ID: 10973224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
    Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
    Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
    Matsuzaki K; Deng G; Tanaka H; Kakar S; Miura S; Kim YS
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8564-9. PubMed ID: 16361538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report.
    Castorina S; Barresi V; Luca T; Privitera G; Musso N; Capizzi C; Condorelli DF
    Ital J Anat Embryol; 2010; 115(1-2):39-45. PubMed ID: 21072988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma].
    Peng Z; Ling Y; Bai S
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):336-9. PubMed ID: 11798895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
    Lake SL; Coupland SE; Taktak AF; Damato BE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.